Catalyst
Slingshot members are tracking this event:
AbbVie's (ABBV) Investigational HCV Regimen Receives U.S. FDA Breakthrough Therapy Designation
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ABBV |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 30, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Hcv Regimen, Breakthrough Therapy Designation
